DLEU1 is upregulated in GBM, and its knockout inhibits GBM cell proliferation and apoptosis, while sensitizing tumor cells to temozolomide (Liu et al., 2019; Lv et al., 2020). This evidence concerns the gene DLEU1 and neoplasm.